Skip to main content
PMC home page
Thorax logoLink to Thorax
. 1993 Apr;48(4):309–316. doi: 10.1136/thx.48.4.309

Effects of high dose inhaled beclomethasone dipropionate, 750 micrograms and 1500 micrograms twice daily, and 40 mg per day oral prednisolone on lung function, symptoms, and bronchial hyperresponsiveness in patients with non-asthmatic chronic airflow obstruction.

D C Weir 1, P S Burge 1
PMCID: PMC464423  PMID: 8511727

Abstract

BACKGROUND--The effect of treatment with inhaled corticosteroids in patients with non-asthmatic chronic airflow obstruction is still disputed. Whether any physiological improvements seen are accompanied by changes in bronchial responsiveness and symptoms and quality of life is also still unclear. METHODS--A sequential placebo controlled, blinded parallel group study investigating the effect of three weeks of treatment with inhaled beclomethasone dipropionate (BDP), 750 micrograms or 1500 micrograms twice daily, and oral prednisolone, 40 mg per day, was carried out in 105 patients with severe non-asthmatic chronic airflow obstruction (mean age 66 years, mean forced expiratory volume in one second (FEV1) 1.05 litres [40% predicted], geometric mean PD20 0.52 mumol). End points assessed were FEV1, forced vital capacity (FVC), and peak expiratory flow (PEF), bronchial responsiveness to inhaled histamine, and quality of life as measured by a formal quality of life questionnaire. RESULTS--Both doses of BDP produced equivalent, small, but significant improvements in FEV1 (mean 48 ml), FVC (mean 120 ml), and PEF (mean 12.4 l/min). The addition of oral prednisolone to the treatment regime in two thirds of the patients did not produce any further improvement in these parameters. Inhaled BDP produced a treatment response in individual patients (defined as an improvement in FEV1, FVC, or mean PEF of at least 20% compared with baseline values) more commonly than placebo (34% v 15%). The two doses of BDP were equally effective in this respect and again no further benefit of treatment with oral prednisolone was noted. Treatment with BDP for up to six weeks did not affect bronchial responsiveness to histamine. Small but significant improvements were seen in dyspnoea during daily activities, and the feeling of mastery over the disease. CONCLUSIONS--High dose inhaled BDP is an effective treatment for patients with chronic airflow obstruction not caused by asthma. Both objective and subjective measures show improvement. Unlike asthma, no improvement in bronchial responsiveness was detected after six weeks of treatment.

Full text

PDF
309

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adelroth E., Rosenhall L., Johansson S. A., Linden M., Venge P. Inflammatory cells and eosinophilic activity in asthmatics investigated by bronchoalveolar lavage. The effects of antiasthmatic treatment with budesonide or terbutaline. Am Rev Respir Dis. 1990 Jul;142(1):91–99. doi: 10.1164/ajrccm/142.1.91. [DOI] [PubMed] [Google Scholar]
  2. Anthonisen N. R., Wright E. C., Hodgkin J. E. Prognosis in chronic obstructive pulmonary disease. Am Rev Respir Dis. 1986 Jan;133(1):14–20. doi: 10.1164/arrd.1986.133.1.14. [DOI] [PubMed] [Google Scholar]
  3. Auffarth B., Postma D. S., de Monchy J. G., van der Mark T. W., Boorsma M., Koëter G. H. Effects of inhaled budesonide on spirometric values, reversibility, airway responsiveness, and cough threshold in smokers with chronic obstructive lung disease. Thorax. 1991 May;46(5):372–377. doi: 10.1136/thx.46.5.372. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Ebden P., Jenkins A., Houston G., Davies B. H. Comparison of two high dose corticosteroid aerosol treatments, beclomethasone dipropionate (1500 micrograms/day) and budesonide (1600 micrograms/day), for chronic asthma. Thorax. 1986 Nov;41(11):869–874. doi: 10.1136/thx.41.11.869. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Eliasson O., Degraff A. C., Jr The use of criteria for reversibility and obstruction to define patient groups for bronchodilator trials. Influence of clinical diagnosis, spirometric, and anthropometric variables. Am Rev Respir Dis. 1985 Oct;132(4):858–864. doi: 10.1164/arrd.1985.132.4.858. [DOI] [PubMed] [Google Scholar]
  6. Engel T., Heinig J. H., Madsen O., Hansen M., Weeke E. R. A trial of inhaled budesonide on airway responsiveness in smokers with chronic bronchitis. Eur Respir J. 1989 Nov;2(10):935–939. [PubMed] [Google Scholar]
  7. Evans J. A., Morrison I. M., Saunders K. B. A controlled trial of prednisone, in low dosage, in patients with chronic airways obstruction. Thorax. 1974 Jul;29(4):401–406. doi: 10.1136/thx.29.4.401. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. GLYNN A. A., MICHAELS L. Bronchial biopsy in chronic bronchitis and asthma. Tip Fak Mecm. 1960 Jun;23:142–153. doi: 10.1136/thx.15.2.142. [DOI] [PubMed] [Google Scholar]
  9. Guyatt G. H., Berman L. B., Townsend M., Pugsley S. O., Chambers L. W. A measure of quality of life for clinical trials in chronic lung disease. Thorax. 1987 Oct;42(10):773–778. doi: 10.1136/thx.42.10.773. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Guyatt G. H., Townsend M., Pugsley S. O., Keller J. L., Short H. D., Taylor D. W., Newhouse M. T. Bronchodilators in chronic air-flow limitation. Effects on airway function, exercise capacity, and quality of life. Am Rev Respir Dis. 1987 May;135(5):1069–1074. doi: 10.1164/arrd.1987.135.5.1069. [DOI] [PubMed] [Google Scholar]
  11. HURFORD J. V., LITTLE G. M., LOUDON H. W. THE USE OF PREDNISOLONE IN CHRONIC BRONCHITIS. Br J Dis Chest. 1963 Jul;57:133–139. doi: 10.1016/s0366-0850(63)80058-7. [DOI] [PubMed] [Google Scholar]
  12. Harding S. M., Freedman S. A comparison of oral and inhaled steroids in patients with chronic airways obstruction: features determining response. Thorax. 1978 Apr;33(2):214–218. doi: 10.1136/thx.33.2.214. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Kerrebijn K. F., van Essen-Zandvliet E. E., Neijens H. J. Effect of long-term treatment with inhaled corticosteroids and beta-agonists on the bronchial responsiveness in children with asthma. J Allergy Clin Immunol. 1987 Apr;79(4):653–659. doi: 10.1016/s0091-6749(87)80163-x. [DOI] [PubMed] [Google Scholar]
  14. Kraan J., Koëter G. H., vd Mark T. W., Sluiter H. J., de Vries K. Changes in bronchial hyperreactivity induced by 4 weeks of treatment with antiasthmatic drugs in patients with allergic asthma: a comparison between budesonide and terbutaline. J Allergy Clin Immunol. 1985 Oct;76(4):628–636. doi: 10.1016/0091-6749(85)90786-9. [DOI] [PubMed] [Google Scholar]
  15. Lam W. K., So S. Y., Yu D. Y. Response to oral corticosteroids in chronic airflow obstruction. Br J Dis Chest. 1983 Apr;77(2):189–198. doi: 10.1016/0007-0971(83)90027-x. [DOI] [PubMed] [Google Scholar]
  16. McGavin C. R., Artvinli M., Naoe H., McHardy G. J. Dyspnoea, disability, and distance walked: comparison of estimates of exercise performance in respiratory disease. Br Med J. 1978 Jul 22;2(6132):241–243. doi: 10.1136/bmj.2.6132.241. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Ollerenshaw S. L., Woolcock A. J. Characteristics of the inflammation in biopsies from large airways of subjects with asthma and subjects with chronic airflow limitation. Am Rev Respir Dis. 1992 Apr;145(4 Pt 1):922–927. doi: 10.1164/ajrccm/145.4_Pt_1.922. [DOI] [PubMed] [Google Scholar]
  18. Pride N. B., Vermeire P., Allegra L. Diagnostic labels applied to model case histories of chronic airflow obstruction. Responses to a questionnaire in 11 North American and Western European countries. Eur Respir J. 1989 Sep;2(8):702–709. [PubMed] [Google Scholar]
  19. Quackenboss J. J., Lebowitz M. D., Krzyzanowski M. The normal range of diurnal changes in peak expiratory flow rates. Relationship to symptoms and respiratory disease. Am Rev Respir Dis. 1991 Feb;143(2):323–330. doi: 10.1164/ajrccm/143.2.323. [DOI] [PubMed] [Google Scholar]
  20. Rudd R. Corticosteroids in chronic bronchitis. Br Med J (Clin Res Ed) 1984 May 26;288(6430):1553–1554. doi: 10.1136/bmj.288.6430.1553. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Shim C., Stover D. E., Williams M. H., Jr Response to corticosteroids in chronic bronchitis. J Allergy Clin Immunol. 1978 Dec;62(6):363–367. doi: 10.1016/0091-6749(78)90137-9. [DOI] [PubMed] [Google Scholar]
  22. Stoller J. K., Gerbarg Z. B., Feinstein A. R. Corticosteroids in stable chronic obstructive pulmonary disease: reappraisal of efficacy. J Gen Intern Med. 1987 Jan-Feb;2(1):29–35. doi: 10.1007/BF02596248. [DOI] [PubMed] [Google Scholar]
  23. Wardman A. G., Simpson F. G., Knox A. J., Page R. L., Cooke N. J. The use of high dose inhaled beclomethasone dipropionate as a means of assessing steroid responsiveness in obstructive airways disease. Br J Dis Chest. 1988 Apr;82(2):168–171. doi: 10.1016/0007-0971(88)90038-1. [DOI] [PubMed] [Google Scholar]
  24. Watson A., Lim T. K., Joyce H., Pride N. B. Failure of inhaled corticosteroids to modify bronchoconstrictor or bronchodilator responsiveness in middle-aged smokers with mild airflow obstruction. Chest. 1992 Feb;101(2):350–355. doi: 10.1378/chest.101.2.350. [DOI] [PubMed] [Google Scholar]
  25. Weir D. C., Gove R. I., Robertson A. S., Burge P. S. Corticosteroid trials in non-asthmatic chronic airflow obstruction: a comparison of oral prednisolone and inhaled beclomethasone dipropionate. Thorax. 1990 Feb;45(2):112–117. doi: 10.1136/thx.45.2.112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Weir D. C., Robertson A. S., Gove R. I., Burge P. S. Time course of response to oral and inhaled corticosteroids in non-asthmatic chronic airflow obstruction. Thorax. 1990 Feb;45(2):118–121. doi: 10.1136/thx.45.2.118. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Weir D. C., Sherwood Burge P. Measures of reversibility in response to bronchodilators in chronic airflow obstruction: relation to airway calibre. Thorax. 1991 Jan;46(1):43–45. doi: 10.1136/thx.46.1.43. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Yan K., Salome C., Woolcock A. J. Rapid method for measurement of bronchial responsiveness. Thorax. 1983 Oct;38(10):760–765. doi: 10.1136/thx.38.10.760. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES